Published On: Wed, Oct 19th, 2016

Heska Corporation (HSKA) Analyst Review


A number of investment brokers have recently updated their price targets on shares of Heska Corporation (HSKA).

Most recent broker ratings

09/21/2016 – Heska Corporation was downgraded to “neutral” by analysts at B. Riley. They now have a USD 53 price target on the stock.

08/04/2016 – Heska Corporation was downgraded to “hold” by analysts at Gabelli.

07/01/2016 – Sidoti began new coverage on Heska Corporation giving the company a “buy” rating. They now have a USD 49 price target on the stock.

12/30/2014 – Heska Corporation was downgraded to “neutral” by analysts at Zacks. They now have a USD 19.6 price target on the stock.

05/10/2014 – Heska Corporation had its “outperform” rating reiterated by analysts at Raymond James. They now have a USD 13 price target on the stock.

03/28/2014 – Heska Corporation was upgraded to “strong-buy” by analysts at Feltl & Co..

The share price of Heska Corporation (HSKA) was up +0.77% during the last day of trading, with a day high of 54.08. 44097 shares were traded during the last session.

The stock’s 50 day moving average is 54.42 and its 200 day moving average is 42.66. The stock’s market capitalization is 369.88M. Heska Corporation has a 52-week low of 26.26 and a 52-week high of 57.41.

Heska Corporation develops, manufactures, markets, sells and supports veterinary products. The Company focuses on the canine and feline companion animal health markets. Its segments include Core Companion Animal Health segment, which includes, primarily for canine and feline use, blood testing instruments and supplies, digital imaging products, software and services, and single use products and services, such as heartworm diagnostic tests, heartworm preventive products, allergy immunotherapy products and allergy testing, and Other Vaccines, Pharmaceuticals and Products segment, which includes private label vaccine and pharmaceutical production, primarily for cattle but also for other animals, including small mammals. It offers blood testing instruments and supplies, digital imaging products, software and services, and single use products and services, such as in-clinic heartworm diagnostic tests, heartworm preventive products, allergy immunotherapy products and allergy testing.